Risk Factors of Sexual Dysfunction in Depressive Patients: A Cross-sectional Observational Multi-center Survey Using ASEX-CV in Taiwan

性功能障礙的相關風險因子於憂鬱症患者的研究：應用亞利桑那性經驗量表中文版（ASEX-CV）在台灣一項橫切面觀察式多中心之調查

成毓賢(Yu- Shian Cheng)；劉嘉逸(Chia-Yih Liu)；沈武典(Winston W. Shen)；文榮光(Jung-Kwang Wen)；吳景寬(Ching-Kuan Wu)

depression ； antidepressant ； sexual dysfunction ； prevalence ； 憂鬱症 ； 抗憂鬱藥物 ； 性功能障礙 ； 盛行率

台灣精神醫學

31卷2期（2017 / 06 / 01）

159 - 169+iv

英文

Objective: In this study, we intended to assess the prevalence and the potential risk factors of sexual dysfunction in depressive patients with Arizona Sexual Experiences Scale-Chinese Version (ASEX-CV). Methods: In this study, we recruited 604 participants from psychiatric outpatient clinics in four different hospitals from June 2004 to October 2005. All participants completed copies of ASEXCV and Taiwanese Depression Questionnaire. We did correlation study between sexual function and antidepressant use, demographics, physical illnesses or severity of depressive symptoms. Results: The overall prevalence of sexual dysfunction was 65.2%. Factors associated with significantly increased risk of sexual dysfunction included female gender (p ＜ 0.001), older age (p ＜ 0.05), divorced or widowed marital status (p ＜ 0.01), more severe depressive symptoms (p ＜ 0.001), prostate diseases (p ＜ 0.01) and menstruation-related illness (p ＜ 0.01). Antidepressant use was not associated with increased risk of sexual dysfunction and lower risk was found in patients using norepinephrine and specific serotonin antidepressant (NaSSA) (p ＜ 0.05). Conclusion: Our study showed that the overall prevalence of sexual dysfunction was high. We suggest that clinicians should ask patients specifically about their sexual side effects of antidepressants, especially in those with high risk factors.

目的：應用亞利桑那性經驗量表中文版(ASEX-CV)來評估台灣憂鬱症病人性功能障礙的盛行率與相關風險因子。方法：本研究從西元2004年六月至2005年十月，由四家不同醫院招募到604位憂鬱症病人。統計上本研究使用迴歸分析方法來探討性功能與人口學資料，生理疾病，憂鬱症嚴重程度和抗憂鬱藥物的使用之間的關聯性。結果：研究發現性功能障礙盛行率在憂鬱病人者高達65.2%。性功能障礙的相關風險因子包括女性(p ＜ 0.001)、年齡增加(p ＜ 0.05)、離婚或寡居(p ＜ 0.01)、嚴重的憂鬱症狀(p ＜ 0.001)、前列腺疾病(p ＜ 0. 01)和月經相關障礙(p ＜ 0.01)。抗憂鬱藥物的使用沒有和性功能障礙盛行率的提升有相關性，而性功能障礙的盛行率在使用NaSSA的病人顯著較低 (p ＜ 0.05)。結論：本研究點出性功能障礙盛行率在憂鬱病人相當的高，建議臨床醫師在照顧憂鬱症病人時須特別注意性功能障礙的影響，尤其是針對風險群須更注意。

1. Angst, J(1998).Sexual problems in healthy and depressed persons.Int Clin Psychopharmacol,13(Suppl 6),S1-S4.
2. Avis, NE(2000).Sexual function and aging in men and women: community and population-based studies.J Gend Specif Med,3,37-41.
3. Baldwin, D,Bridgman, K,Buis, C(2006).Resolution of sex- ual dysfunction during double-blind treatment of ma- jor depression with reboxetine or paroxetine.J Psychopharmacol,20,91-96.
4. Bishop, JR,Ellingrod, VL,Akroush, M,Moline, J(2009).The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)- associated sexual side effects: possible relationship to oral contraceptives.Hum Psychopharmacol,24,207-215.
5. Bishop, JR,Moline, J,Ellingrod, VL,Schultz, SK,Clayton, AH(2006).Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-ef- fects.Neuropsychopharmacology,31,2281-2288.
6. Chen, KC,Yang, YK,Lee, IH(2008).Sexual dysfunc- tion and physicians' perception in medicated patients with major depression in Taiwan.Depress Anxiety,25,E56-E62.
7. Chen, KC,Yeh, TL,Lee, IH(2009).Age, gender, de- pression, and sexual dysfunction in Taiwan.J Sex Med,6,3056-3062.
8. Clayton, AH,Pradko, JF,Croft, HA(2002).Prevalence of sexual dysfunction among newer antidepressants.J Clin Psychiatry,63,357-366.
9. Cyranowski, JM,Frank, E,Cherry, C,Houck, P,Kupfer, DJ(2004).Prospective assessment of sexual function in women treated for recurrent major depression.J Psychiatr Res,38,267-273.
10. Delgado, PL,Brannan, SK,Mallinckrodt, CH(2005).Sexual functioning assessed in 4 double-blind place- bo- and paroxetine-controlled trials of duloxetine for major depressive disorder.J Clin Psychiatry,66,686-692.
11. Demyttenaere, K,Jaspers, L(2008).Review: Bupropion and SSRI-induced side effects.J Psychopharmacol,22,792-804.
12. Dunn, JA,Arakawa, R,Greist, JH,Clayton, AH(2007).Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technol- ogy.J Clin Psychiatry,68,525-532.
13. Gartlehner, G,Hansen, RA,Morgan, LC(2011).Comparative benefits and harms of second-genera- tion antidepressants for treating major depressive disorder: an updated meta-analysis.Ann Intern Med,155,772-785.
14. Hirschfeld, RM(1999).Care of the sexually active depressed patient.J Clin Psychiatry,60(Suppl 17),32-35+46-48.
15. Hueng, TT,Lee, IH,Guog, YJ(2011).Is a patient-ad- ministered depression rating scale valid for detecting cognitive deficits in patients with major depressive disorder?.Psychiatry Clin Neurosci,65,70-76.
16. Kennedy, SH,Eisfeld, BS,Dickens, SE,Bacchiochi, JR,Bagby, RM(2000).Antidepressant-induced sexual dys- function during treatment with moclobemide, parox- etine, sertraline, and venlafaxine.J Clin Psychiatry,61,276-281.
17. Lee, KU,Lee, YM,Nam, JM(2010).Antidepressant- induced sexual dysfunction among newer antidepres- sants in a naturalistic setting.Psychiatry Investig,7,55-59.
18. Lee, TI,Issac, J,Lin, SH(2013).Gender difference in antidepressant-related sexual dysfunction in Taiwan.Gen Hosp Psychiatry,35,407-411.
19. Lee, Y,Yang, MJ,Lai, TJ,Chiu, NM,Chau, TT(2000).Development of the Taiwanese Depression Questionnaire.Chang Gung Med J,23,688-694.
20. Lewis, RW,Fugl-Meyer, KS,Corona, G(2010).Definitions/epidemiology/risk factors for sexual dys- function.J Sex Med,7,1598-1607.
21. Liang, CS,Ho, PS,Chiang, KT,Su, HC(2012).5-HT2A re- ceptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospec- tive exploratory study.J Sex Med,9,2009-2016.
22. McGahuey, CA,Gelenberg, AJ,Laukes, CA(2000).The Arizona Sexual Experience Scale (ASEX): reli- ability and validity.J Sex Marital Ther,26,25-40.
23. Michelson, D,Schmidt, M,Lee, J,Tepner, R(2001).Changes in sexual function during acute and six-month fluox- etine therapy: a prospective assessment.J Sex Marital Ther,27,289-302.
24. Montejo, AL,Llorca, G,Izquierdo, JA,Rico-Villademoros, F(2001).Incidence of sexual dysfunction as- sociated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-related Sexual Dysfunction.J Clin Psychiatry,62(Suppl 3),10-21.
25. Montgomery, SA(1995).Safety of mirtazapine: a review.Int Clin Psychopharmacol,10(Suppl 4),37-45.
26. Roth, A,Kalter-Leibovici, O,Kerbis, Y(2003).Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.Clin Cardiol,26,25-30.
27. Saiz-Ruiz, J,Montes, JM,Ibanez, A(2005).Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.Hum Psychopharmacol,20,435-440.
28. Seidman, SN,Roose, SP(2000).The relationship between depression and erectile dysfunction.Curr Psychiatry Rep,2,201-205.
29. Serretti, A,Chiesa, A(2009).Treatment-emergent sexual dysfunction related to antidepressants: a meta-analy- sis.J Clin Psychopharmacol,29,259-266.
30. Soykan, A(2004).The reliability and validity of Arizona sexual experiences scale in Turkish ESRD patients undergoing hemodialysis.Int J Impot Res,16,531-534.
31. Tuinman, MA,Hoekstra, HJ,Vidrine, DJ(2010).Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudi- nal study.Psycho-oncology,19,238-247.
32. Watanabe, N,Omori, IM,Nakagawa, A(2011).Mirtazapine versus other antidepressive agents for depression.Cochrane Database Syst Rev,12,CD006528.
33. Wen, JK(2006).Sexual Belief, Gender Difference, and Tolerability to Antidepressant Induced Sexual Dysfunction in Taiwanese Patients.J Sex Res,43,29.
34. Wen, JK(1995).Sexual beliefs and problems in contempo- rary Taiwan.New York:Oxford University Press.
35. Wen, JK,H, C,Chen, SW,Jing, JH,Chu, YJ(2006).Validity and reliability of Arizona Sexual Experiences Scale- Chinese Version (ASEX-CV) in the clinical study of outpatients with depressive disorder and sexual dys- function.Proceedings of the Annual Meeting of the Taiwanese Society of Psychiatry,Tainan:
36. Williams, VS,Baldwin, DS,Hogue, SL(2006).Estimating the prevalence and impact of antidepres- sant-induced sexual dysfunction in 2 European coun- tries: a cross-sectional patient survey.J clin Psychiatry,67,204-210.
37. Williams, VS,Edin, HM,Hogue, SL,Fehnel, SE,Baldwin, DS(2010).Prevalence and impact of antidepres- sant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient sur- vey.J Psychopharmacol,24,489-496.
38. Zemishlany, Z,Weizman, A(2008).The impact of mental ill- ness on sexual dysfunction.Adv Psychosom Med,29,89-106.